Connect with us


Hope hydroxychloroquine despairs despite medical research detailing drug failures being withdrawn




A month ago, approximately 70% of COVID-19 patients treated at the 13 Hackensack Meridian Health System hospitals in New Jersey were given hydroxychloroquine as part of their care.

That is no longer the case. Clinicians and hospital managers made decisions according to a series of clinical studies, including an internal study published May 27. Preprint According to Dr. Stuart Goldberg, a doctor at the Hackensack University Medical Center, a drug that has long been used as an antimalarial drug did not improve the outcome of hospitalized COVID-19 patients.

read: So far, there is little evidence of chloroquine as a COVID-19 drug, but it is already in short supply

Hydroxychloroquine became a household name when President Donald Trump and other members of the government’s Coronavirus Task Force joined in March. First we discussed the possibility publicly As COVID-19 treatment. However, the drug has faced steady scientific and political scrutiny as to whether it actually helps treat or prevent coronavirus infections. At the same time, there are growing questions about the integrity of medical research during periods of overload of clinical and scientific information, and the political promotion of unidentified therapies.

“Politics played a role, driving people from doing good science,” said Goldberg. “As a scientist, it offends me…it scares the public that scientists are not doing their jobs.”

The pros and cons of hydroxychloroquine have come a tortuous path in recent weeks, with an increasing number of studies finding that the drug may not be effective in treating or preventing COVID-19. However, the closely monitored studies published in leading medical journals now also face scrutiny of potential inaccuracies in the data. Was withdrawn Thursday afternoon.

“The protection and widespread use of hydroxychloroquine seems to reflect a reasonable fear of SARS-CoV-2 infection,” said Dr. Myron Cohen, a doctor at the University of North Carolina at Chapel Hill. June 3 Editorial New England Medical Journal. “But to some extent media and social forces, rather than medical evidence, appear to drive clinical decisions and the global COVID-19 research agenda.”

Here is a summary of the past two weeks:

• The lancet Investigation The results showed that hydroxychloroquine did not benefit patients hospitalized with COVID-19 and had an increased risk of ventricular arrhythmias and in-hospital mortality. Hundreds of doctors and researchers letter To the Lancet editor raising concerns about data and analysts. One fix Made, Lancet placed what it callsExpressing concern, And the authors withdrew the study. “We cannot guarantee the authenticity of the primary data source,” they wrote.

• The study called on the World Health Organization (WHO) to suspend its own drug research. France And some other countries in Europe do not recommend the use of drugs in COVID-19 patients.

• Then on Wednesday the WHO It resumes the trial.. (“Based on available mortality data, the committee members recommended that there is no reason to change the clinical trial protocol,” WHO Director-General Dr. Tedros Adhanom Ghebreyesus wrote on Twitter.

• A few hours later, the much anticipated University of Minnesota Investigation Published in the New England Journal of Medicine, the drug failed to prevent COVID-19 infections. “I’m disappointed that this didn’t prevent COVID-19, but I’m pleased to have provided a definitive answer,” said Dr. David Bourware, senior investigator at the University of Minnesota trial. Stated. “Our purpose was to find the answer.”

Bayer AG first publicly talked about hydroxychloroquine during and several weeks after administration.
+ 0.05%
And Teva Pharmaceutical Co., Ltd.

We promised to donate millions of doses of drugs to the Federal Reserve. (Hydroxychloroquine is commonly used as a treatment for malaria, rheumatoid arthritis, lupus, and all indications are approved by the Food and Drug Administration.)

A week later, the Food and Drug Administration gave some restrictions on how to prescribe hydroxychloroquine and chloroquine, which are old licenses of the same drug as hydroxychloroquine, an emergency license.

See alsoHydroxychloroquine creates new controversy, but clinical trials are moving forward

Several pharmaceutical companies including Novartis AG

And sanofi
+ 0.77%

And medical researchers, and National Institutes of Health WHO has initiated a clinical trial aimed at assessing the efficacy of the drug in patients with COVID-19.

Sanofi suspended the investigation, similar to WHO. A Sanofi spokesperson said in an email, saying the company will “check the available information and consult with others to reassess our position in the next few days.”

Novartis said it is proceeding.

“We carefully monitor our clinical trials and other studies conducted using the HCQ and are the best informants of our approach to clinical trials. At this point we are suspending our work on the trial. There is no evidence of controlled testing to do.”

Some analysts are increasingly pessimistic about the potential of hydroxychloroquine as a treatment for COVID-19. Raymond James analyst Steven Seedhouse told investors this week that “HCQ is unlikely to be an effective treatment in our view once the infection is confirmed.”


What Are The Main Benefits Of Comparing Car Insurance Quotes Online

LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos

Pictures Credit


to request, modification Contact us at Here or [email protected]